Carl Zeiss Meditec (ETR:AFX) Stock Price Down 1.8% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFX)’s stock price traded down 1.8% during mid-day trading on Wednesday . The stock traded as low as €25.50 and last traded at €25.78. 160,411 shares changed hands during trading, an increase of 70% from the average session volume of 94,405 shares. The stock had previously closed at €26.24.

Carl Zeiss Meditec Stock Performance

The firm has a market capitalization of $2.40 billion, a P/E ratio of 13.78, a price-to-earnings-growth ratio of 2.83 and a beta of 1.33. The company has a current ratio of 2.43, a quick ratio of 2.47 and a debt-to-equity ratio of 29.43. The company has a 50-day moving average of €26.09 and a 200-day moving average of €30.91.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.